Mahmoud Reza Jaafari
Mashhad University of Medical Sciences
383 Papers
1.2K Citations
Mahmoud Reza Jaafari is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Liposome & Medicine. The author has an hindex of 46, co-authored 323 publications. Previous affiliations of Mahmoud Reza Jaafari include University of California, San Francisco & University of Saskatchewan.
Chat about Author
Papers
PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.
TL;DR: The results showed that immunization of mice with a high level of PEG did not improve protective immunity of liposomal SLA, and the presence of P EG, particularly more than 3.75%, is not recommended for protection against leishmaniasis.
7
P0 Protein Mediated Targeting of Liposomes to Melanoma Cells with High Level of ICAM-1 Expression
Mahmoud Reza Jaafari,Foldvari M +1 more
TL;DR: P0 protein or its binding domain(s) that mediate the targeting of liposomes through adhesive interactions may be useful for the development of novel types of drug delivery systems and in the treatment of metastatic cancers, inflammation and viral diseases.
7
Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study.
Fatemeh Gheybi,Alireza Khooei,Azamsadat Hoseinian,Maham Doagooyan,K. Houshangi,Mahmoud Reza Jaafari,Arash Papi,Zahra Khoddamipour,Amirhossein Sahebkar,Seyedeh Hoda Alavizadeh +9 more
TL;DR: The results of this study support the significant hepatoprotective effect of SLB nanoliposomes against acetaminophen-induced toxicity depending on the route of administration.
7
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
Sahar Tahaghoghi-Hajghorbani,Mona Yazdani,Amin Reza Nikpoor,Mahdi Hatamipour,Abolghasem Ajami,Mahmoud Reza Jaafari,Ali Badiee,Alireza Rafiei +7 more
TL;DR: In this article , the authors used Lip-EPA as a combination approach with liposomal gp100 (Lip-gp100) anti-cancer vaccine in melanoma model.